Elutia (ELUT) Interest & Investment Income (2025 - 2026)
Elutia's (ELUT) quarterly Interest & Investment Income came in at $35000.0 in Q2 2026, down 94.17% year-over-year from $600000.0 in Q2 2025, and down 67.59% quarter-over-quarter from $108000.0 in Q1 2026.
Powered by 
Analysis
Elutia (ELUT) Interest & Investment Income (2025 - 2026) Analysis & Trends
Elutia has disclosed Interest & Investment Income across 2 years of filings, most recently posting $35000.0 for Q2 2026.
- In Q2 2026, Interest & Investment Income fell 94.17% year-over-year to $35000.0; the TTM figure through Jun 2026 stood at $559000.0 (changed N/A YoY), while the FY2025 annual figure was $387000.0, up 141.43% from the prior year.
- Interest & Investment Income came in at $35000.0 for Q2 2026 at Elutia, down from $108000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $600000.0 in Q2 2025 to a low of -$184000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | - |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | - |
| 10 | Elutia | 34.94 Mn | 15.04 Mn | 1.45 Mn | 35,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | -184,000.00 |